Por favor, use este identificador para citar o enlazar este Item:http://hdl.handle.net/20.500.12105/18858
Título
Myocarditis Related to COVID-19 and SARS-CoV-2 Vaccination.
Autor(es)
Molina-Ramos, Ana I | Gómez-Moyano, Elisabeth | Rodríguez-Capitán, Jorge | Angullo-Gómez, María | Gallardo-Jiménez, Patricia | Pérez de Pedro, Iván | Valiente de Santis, Lucía | Pérez-Villardón, Beatriz | Piñero-Uribe, Isabel | Mora-Robles, Javier | Becerra-Muñoz, Víctor Manuel | Jiménez-Navarro, Manuel
Fecha de publicación
2022-11-26
Idioma
Inglés
Tipo de documento
research article
Resumen
The coronavirus disease of 2019 (COVID-19) has been a cause of significant morbidity and mortality worldwide. Among the short- and long-term consequences of COVID-19, myocarditis is a disease to be taken into consideration. Myocarditis, in general, is related to a poor prognosis. However, the epidemiology and prognosis of myocarditis related to COVID-19 are currently unknown. While vaccination against COVID-19 is of great benefit at a public health level, the risk of myocarditis should be considered in the context of the global benefits of vaccination. In this narrative review, we will summarize the etiopathogenic bases, the epidemiology, the clinical manifestations, the course, diagnosis, prognosis, and the treatment of myocarditis related to SARS-CoV-2, as well as myocarditis secondary to mRNA vaccines.
Palabras clave
DOI
Aparece en las colecciones
Acceso a texto completo